PHASE II TRIAL OF MOXIFLOXACIN FOR TB
$453,224R01FY2006FDFDA
Johns Hopkins University, Baltimore MD
Investigators
Linked publications & trials
Abstract
Abstract Not Provided
View original record on NIH RePORTER →Johns Hopkins University, Baltimore MD
Abstract Not Provided
View original record on NIH RePORTER →